Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection C Riou, E Du Bruyn, C Stek, R Daroowala, RT Goliath, F Abrahams, ... The Journal of clinical investigation 131 (12), 2021 | 143 | 2021 |
Plasma pharmacokinetics of high-dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial S Wasserman, A Davis, C Stek, M Chirehwa, S Botha, R Daroowala, ... Antimicrobial agents and chemotherapy 65 (8), 10.1128/aac. 00140-21, 2021 | 28 | 2021 |
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa E Du Bruyn, C Stek, R Daroowala, Q Said-Hartley, M Hsiao, G Schafer, ... Nature communications 14 (1), 188, 2023 | 20 | 2023 |
A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus–associated … AG Davis, S Wasserman, C Stek, M Maxebengula, C Jason Liang, ... Clinical Infectious Diseases 76 (8), 1412-1422, 2023 | 16 | 2023 |
Profile of SARS-CoV-2-specific CD4 T cell response: Relationship with disease severity and impact of HIV-1 and active Mycobacterium tuberculosis co-infection C Riou, E Bruyn, C Stek, R Daroowala, RT Goliath, F Abrahams, ... medRxiv, 2021.02. 16.21251838, 2021 | 10 | 2021 |
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated … AG Davis, S Wasserman, M Maxebengula, C Stek, M Bremer, ... Wellcome Open Research 6, 2021 | 8 | 2021 |
High resolution imaging and five-year tuberculosis contact outcomes H Esmail, AK Coussens, F Thienemann, B Sossen, SL Mukasa, J Warwick, ... medRxiv, 2023 | 4 | 2023 |
Communicable and non-communicable co-morbidities and the presentation of COVID-19 in an African setting of high HIV-1 and tuberculosis prevalence E du Bruyn, C Stek, R Daroowala, Q Said-Hartley, M Hsiao, RT Goliath, ... medRxiv, 2021.05. 11.21256479, 2021 | 4 | 2021 |
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa E Bruyn, C Stek, R Daroowala, Q Said-Hartley, M Hsiao, G Schafer, ... Nature Communications 14 (1), 1-13, 2023 | 1 | 2023 |